Target intelligence / Profile preview

Duodenal mucosal surface

Molecular classification
Other
01

Overview

The duodenal mucosal surface is the innermost epithelial lining of the first part of the small intestine, functioning as a vital interface for digestion and absorption. It is characterized by a complex architecture of villi and microvilli that maximize surface area for the uptake of nutrients, electrolytes, and water (StatPearls, 2023). This surface is continuously exposed to harsh gastric acid and digestive enzymes, necessitating robust protective mechanisms such as the secretion of an alkaline mucus layer by Brunner's glands and the maintenance of tight junctions between epithelial cells (NCBI, 2022). Pathologies of the duodenal mucosal surface include peptic ulcer disease, where the barrier is breached, and celiac disease, which involves immune-mediated destruction of the villous structure. While not a single molecular target, it is the physiological site of action for cytoprotective agents like sucralfate, which binds to the surface to form a physical barrier against further acid damage, and misoprostol, which enhances mucosal defense (PubMed, 2021).

Other names
Duodenal mucosaLining of the duodenumMucosa duodeniDuodenal epithelial surface
02

Mechanism of action

Drugs interacting with the duodenal mucosal surface typically function by forming a physical protective barrier over ulcerated tissue, stimulating bicarbonate and mucus production, or neutralizing luminal acidity to prevent epithelial damage.

03

Biological functions

Nutrient absorptionAcid neutralizationMucus secretionBarrier functionHormone production
04

Disease associations

Duodenal ulcerDuodenitisCeliac diseasePeptic ulcer diseaseGastrointestinal hemorrhage
05

Safety considerations

Malabsorption of co-administered drugsAluminum toxicity in renal impairmentConstipationDiarrhea
06

Interacting drugs

Sucralfate

4 more in the full profile.

07

Biomarkers

Endoscopic mucosal appearanceVillous height to crypt depth ratioIntraepithelial lymphocyte countFecal calprotectin

Beyond the preview

Go deeper on Duodenal mucosal surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Duodenal mucosal surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call